mg 11-ketoprogesterone (24) in 0.3 ml propylene glycol. The remaining fetuses in the second uterine horn were injected with injection of 11-ket~pro~esterone into fetal rats at day 17 of 0.3 ml propylene glycol alone. The uterine horn chosen for gestation reduced the pulmonary C-11 activation index (an injection of 11-ketoprogesterone was alternated in successive net gain Or loss glucocorticoid activity) as animals. The abdominal incision was closed and the rats allowed measured at day 21 ( P < 0.001) and resulted in elevated levels to recover. of the inactive hormone 11-dehydrocorticoster~ne ( P < 0.001),
determined.
For the determination of fetal pulmonary 11-oxidoreductase Speculation activity, one lung was taken from each fetus, homogenized, and incubated in Earle's balanced salt solution, pH 7.4 (25) containPrenatal glucocorticoid treatment to accelerate fetal lung ing equimolar amounts (8.3 of [,4Clcortisone pew maturation is an attempt to mimic a physiologic process. Further England Nuclear, lot no. 746-160, sp act 59.8 mCi/mmol: 1.2 that process provide means to enhance 105 dpm) and [3HJcortiso~ (New England Nuclear, lot no. the safety and efficacy of such therapeutic intervention.
853-263, sp act 40 Ci/mmol: 1 .l x lo6 dpm) at a concentration of 1 0 mg tissue/ml. The incubation was carried out in a A large body of experimental evidence suggests that fetal metabolic shaking incubator at 37" for 2 hr under 5 % COz. lung maturation is under the influence of the fetal corticosteroid After the incubation, cortisone and cortisol were extracted, environment ( 1 . 4 , 6 , 11, 15, 19-21) . Corticosteroid biogenesis separated chromatographically, and counted exactly as ~r e v iand metabolism are distinctly different in the fetal, as opposed O U S~Y described (16) . The percentage of conversion of cortisol to the adult, mammal (8) . A~~~~ the important differences is to cortisone (11-oxidation = biologic inactivation) was subthe preponderance of biologically inactive 1 1-ketosteroids (tor- tracted from the percentage of conversion of cortisone to cortisol tisone (23), 1 1-dehydroco~icosterone) over active 1 l&hydroxy-(1 1-reduction = biologic activation) to give the "C-11 activation steroids (cortisol, c o r t i~~s t e r o n e ) (12) . This has been assumed index," an indicator of net gain (or loss) of biologic activity (16) . to be due to a developmental inability of fetal tissues to
The remaining lung of each fetus was processed for the "activate" 1 l-keto-to 1 1 P-hydroxysteroids (1 3, 14) . Neverthequantitation of saturated ph~sphatid~lcholine. They were holess, the fetal lung does possess the necessary enzymic activity mogenized in 15 ml chloroform-methanol (2:1). T o each was (1 1 -reductase) to convert abundant 1 1-ketosteroids to their added 3000 dpm 'r-saturated ~h o s~h a t i d~l c h o l i n e , prepared active 11P-hydroxy-configurations (7, 16, 17, 21, 22) and this in Our laboratory as previously described (20) . ~f t e r refrigeraactivity increases with advancing gestational age (16, 22) . tion overnight at 5°C each sample was shaken with 5 ml We have recently shown that, in both ovine (20) and human aqueous 100 mM KC1 (5). The lower (organic) phase was (19) amniotic fluid, the ratio of cortisol/cortisone is related to removed, filtered, and evaporated to dryness. The lipid extracts the state of fetal lung maturity, and this relationship is statistiwere reacted with osmium tetrOxide, 3.2 mg in 0.5 m1 cally more significant than that of cortisol alone, suggesting that carbon tetrachloride, for 15 min (10, 20) . After drying, satuthe metabolic interrelationship of 1 l-keto-and 1 1~-hydroxycor-rated phosphatidylcholine was isolated by column chromatograticosteroids plays a role in the process of fetal lung development.
phy Over neutral alumina (lo, 20)* and quantitated by the ~h~ present study was initiated to determine this Bartlett phosphorus assay (2) with results corrected for experisupposition might be correct, by observing the effect on pulmomental losses the recovery added nary maturation in the fetal rat of injection of an inhibitor of The fetal carcasses were homogenized in 30 ml ethyl acetate pulmonary steroid 1 1-reductase activity (1 1-ketoprogesterone) and the hOmOgenates were extracted three times with lo (21) . distilled water. After decolorization with 3 ml 0.1 N NaOH and washing to neutrality (19, 20) , the ethyl acetate extracts were MATERIALS AND METHODS evaporated to dryness and applied to silica gel G plates in a few drops of methylene chloride. The plates were developed in Female Sprague-Dawley rats were bred with a male brown chloroform-methanol (9:l) and areas running with authentic hooded rat under accurately timed conditions in our laboratory.
corticosterone and 11-dehydrocorticosterone standards (24) O n the 17th day of gestation a laparotomy was performed were eluted with ethanol. Aliquots of the eluates were assayed under sterile conditions, using ether anesthesia. The gravid for steroid content by radiotransinassay, using [3H]cortisol as uterus was exposed and, through the translucent uterine wall, ligand, exactly as previously described (19, 20) . For corticosterall fetuses in one horn were injected intraperitoneally with 0.2 one, 5 % human plasma (26) was used as the source of corticos-teroid binding globulin, whereas, in the case of I l-dehydrocorticosterone, 5 % dog plasma (obtained locally) was used. Results are reported as nanograms of steroid per g tissue.
In addition to the experimental litters, the above studies were also carried out on unoperated litters at daily intervals from day 1 7 to day 21 of gestation to provide normal values with which to compare our experimental observations. All values are reported as means 2 SD. Differences between groups of observations have been compared using Student's ttest. 
Controls
Number of litters is shown in parentheses. RESULTS
The surgical procedure was associated with considerable fetal mortality (47%). This, however, could not be attributed to the 11-ketoprogesterone since the fetal loss was 37 % in experimental fetuses and 5 6 % in vehicle-injected controls. In addition, there is a normal background of fetal wastage in late gestation in multigravid species such as the rat, as reflected by a decrease in average litter size from 13 at days 17 and 18 to 8 at day 21 in our nonoperated control group (a reduction of 39%).
Normal body, lung, and adrenal weights for fetal rats bred in our laboratory are shown in Table 1 . As shown, body weight and lung weight increase rapidly over the latter days of gestation, as compared to a more modest rate of increase of adrenal weight. The effect of 11-ketoprogesterone injection on these parameters is shown in Table 2 . It can be seen that body weight was not affected by 11-ketoprogesterone injection (3.6 2 0.5 g) or by vehicle injection alone (3.6 2 0.5 g), since these values d o not differ significantly from those of unoperated 21-day fetuses (3.9 2 0.4 g). In contrast, 11-ketoprogesterone injected fetuses had considerably larger lungs (147.6 2 9.8 mg) than either vehicle-injected controls (132.8 2 9.5 mg, P < 0.001) or normal 21-day fetuses (135.2 2 16.4, P < 0.001). Similarly, adrenal weight was increased by 11-ketoprogesterone injectidn ( P < 0.001).
Normal levels of corticosterone, 11-dehydrocorticosterone, their ratio, and the C-11 activation index are shown in Table 3 . Levels of both steroids increase with advancing gestational age, but corticosterone (the active hormone) rises more rapidly, resulting in a rising ratio. This appears to be due, at least in part, to the rapid increase in the pulmonary C-11 activation index. The greatest increase in corticosterone levels and the corticosterone/l l-dehydrocorticosterone ratio occurs between the 17th and 18th days, when the final stages of lung maturation are initiated. This is accompanied by a shift in the C-11 activation index from a negative value (net inactivation) on day 1 7 to a positive value (net activation) on day 18. As shown in Table 4 , the C-11 activation index on day 21 is strikingly depressed by 11-ketoprogesterone injection ( P < 0.001). This is accompanied by a lowered corticosterone/l l-dehydrocorticosterone ratio ( P < 0.001), explainable by elevated levels of the inactive hormone 11-dehydrocorticosterone ( P < 0.01), since corticosterone levels were unchanged.
In Table 5 is shown the normal increase in pulmonary saturated phosphatidylcholine content which reflects the biochemical maturation of the fetal lung. In Table 6 it can be seen that 11-ketoprogesterone injection reduced saturated phospha- Number of litters is shown in parentheses. tidylcholine, whether considered as mg/g lung weight ( P < 0.001 versus both vehicle injected and unoperated controls) or as milligrams per lung ( P C 0.001 versus vehicle-injected controls; P < 0.05 versus unoperated controls). Saturated phosphatidylcholine was increased in vehicle-injected controls when compared to unoperated controls ( P < 0.01), perhaps reflecting stress-induced acceleration of fetal lung maturation.
DISCUSSION
Injection of fetal rats with 11-ketoprogesterone at day 17 of gestation reduced the pulmonary conversion of the biologically inactive, but abundant, 11-ketosteroid, ll-dehydrocorticosterone, to its biologically active 1 lphydroxy form (corticosterone) and delayed lung maturation as reflected by reduced pulmonary saturated phosphatidylcholine content (the essential component of the pulmonary surfactant) (9) . This would appear to support the concept, derived from indirect evidence (19, 20) , that pulmonary 11-reductase activity facilitates the maturation of the fetal lung.
It is likely that the delayed lung maturation observed is, in fact, due to inhibition of the 11-reductase enzyme system, since, in vitro, this steroid has no effect on saturated phosphatidylcholine biosynthesis, nor does it reduce the effect of active (llphydroxy) glucocorticoid on this process (21) .
The delayed maturation was accompanied by increased lung weight. A similar observation was made when pulmonary maturation was delayed by fetal decapitation (4). Conversely, steroidinduced acceleration of fetal lung maturation is accompanied by reduced pulmonary cellular growth both in vivo (3) and in vitro (18) . Despite significant reduction of pulmonary. 11-reductase activity by 11-ketoprogesterone, as measured directly and as reflected by elevation of precursor (11-dehydrocorticosterone) levels, corticosterone levels remained unchanged. This was accompanied, however, by increased fetal adrenal weight. This may imply that, under normal conditions, fetal pulmonary 11-reductase makes a significant contribution to circulating active 11 phydroxy steroids, but reduction of this contribution can be compensated for by increased fetal pituitary-adrenal activity. The fact that fetal lung maturation was delayed despite normal
